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Abstract
This paper reports a case of endometriosis of the lung in a 29-year-old woman with long-term periodic catamenial
hemoptysis. A chest computed tomography image obtained during menstruation revealed a radiographic opaque
lesion in the lingular segment of the left superior lobe. During bronchoscopy, bleeding in the mucosa of the distal
bronchus of the lingular segment of the left superior lobe was observed. Histopathology subsequent to an
exploratory thoracotomy confirmed the diagnosis of endometriosis of the left lung. The 2-year follow-up after
lingular lobectomy of the left superior lobe showed no recurrence or complications.
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Background
Endometriosis is the presence of functional endometrial
tissue outside the uterus, most commonly in the ovaries,
uterosacral ligaments, and peritoneum. It was first de-
scribed in 1860 [1]. A very common disease in women
worldwide, it affects 5% to 15% of them during their re-
productive years [2]. Although usually confined to the
pelvis, endometriosis is also known to occur in extra-
pelvic organs or tissues; ectopic endometrium has been
found in the umbilicus, abdominal scars, breasts, the ex-
tremities, pleural cavity and lung [3-5]. Although the
symptomatology of extra-pelvic endometriosis is always
coordinated to the menstrual cycle, this is not directly
apparent in all patients and diagnosis is notoriously diffi-
cult. Efforts to estimate the prevalence of extra-pelvic
endometriosis are hampered by the great variety of
symptoms, signs, locations, and ambiguous diagnosis [6].
Endometriosis of the lung is associated with catame-
nial hemoptysis and chest pain. It is rare, chronic, and
estrogen dependent. Confirmation requires a combin-
ation of clinical symptoms and postoperative histopatho-
logical assessment [7]. Clinical examination often reveals
only occult symptoms and signs, but severe cases can re-
sult in extensive decidual adhesions and distortion of tis-
sue in the proximity of the decidua. It is these that lead
to catamenial pain and hemoptysis, and the disease can
be suspected in women with these symptoms [8]. The
pathologist’s role is made additionally difficult by the dis-
ease’s many histologic features, from typical endometrial
glands to an abundance of fibrous tissue.
For women with lung endometriosis, surgery is able to
provide radical relief. Because of the high rate of recru-
descence, surgical salvage may be expected [9]. Medical
therapies have historically included administration of
contraceptive progestogens, gonadotropin-releasing hor-
mone agonists, androgens, and non-steroidal anti-
inflammatory drugs. Treatments to lower circulating es-
tradiol concentrations may be useful for only a limited
time due to unacceptable side effects, and changes or
additional medications are commonly needed [10].
Important recent advances in the understanding of
endometriosis hold promise for the development of new
diagnostic and therapeutic approaches that could limit
symptoms and improve fertility [11]. Such new concep-
tual understandings depend on the study of retrieved
endometrial tissue and recognition of the immune re-
sponse associated with endometriosis.
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Case presentation
A 29-year-old woman complained of repetitive and con-
secutive catamenial hemoptysis (coughing up of blood
during menstruation) of one year’s duration, approxi-
mately 5 mL to 10 mL each cycle with blood clots,
which gradually had aggravated. Intriguingly, the
hemoptysis generally started on the first or second day
of each menstruation and thereafter continued for about
6 days, identical with the menstruation interval. The vol-
ume of the hemoptysis increased with the menstruation.
More importantly, the end of hemoptysis coincided with
that of menstruation.
Prior to being seen at our clinic, the patient had taken
prescribed antitubercular drugs for 4 months after being
misdiagnosed as suffering from pulmonary tuberculosis
at the community hospital. Her treatment was ended be-
cause hemoptysis had begun again. Hemostasis and fluid
administration had been administered during the past 8
months. Hemoptysis had become worse 10 days before,
with a hemoptysis volume of 10 mL to 20 mL during
each episode accompanied by dyspnea, coincident with
the start of menstruation.
The patient had no history of weight loss or other ser-
ious illness. She had achieved conception five times,
ending in one normal delivery, one Caesarean section,
and three abortions. A physical examination revealed
coarse rasps in the left-inferior lobe of the lung with
moist rales. A chest radiograph showed irregular nodular
opacity in the middle-exterior field of the left lung with
a symmetric thorax and plain lung markings. Laboratory
findings on admission were as follows: white blood cell
(WBC) count was 6,000/μL, creatinine was 1.4 mg/dL,
the erythrocyte sedimentation rate (ESR) was 10/h,
procalcitonin (PCT) 0.2 ng/mL, C-reactive protein 0.2
mg/dL, AST 38 IU/L, ALT 33 IU/L, LDH 80 IU/L and
Hb 8.1 g/dL. A chest computed tomography (CT) image
taken during the menstrual cycle and just after a
hemoptysis event revealed pneumonia in the left-
superior lobe of the lung (Figure 1A). Bronchoscopy
(Olympus electric bronchoscope BF-P240 with Number
2800560, Olympus CLV-U40 as the host computer and
Olympus CV-240 as the image acquisition system) on
the fourth day of the menstrual cycle was performed and
showed active bleeding in the distal bronchus of the su-
perior segment of the left lingular lobe (Figure 1B).
Bronchoalveolar lavage fluid under the light microscope
was negative for acid-fast bacillus. A fibroid space-
occupying lesion, 2.2 cm × 1.4 cm, with a clearly defined
margin was detectable via pelvic ultrasonography in the
anterior wall of the uterus, although gynecological exam-
ination showed no signs of abnormalities except for
grade-2 erosion of the cervix. Blood cell count and
Figure 1 Clinical findings. (A) CT scan on the third day of menstruation. There was a nearly round opaque nodule (arrow) in the distal part of
the left-superior lobe of the lung. (B) Bronchographic image on the fourth day of menstruation. There was bleeding in the distal bronchus of the
superior segment of the left lingular lobe. (C) Exploration of the lingular lobe of the left lung showed the pleural lamina visceralis was hyperemic
and phlyctenular (arrow). (D) Making an incision in the left lingular lobe. There was a lesion that constituted the foci of an old hemorrhage (thin
arrow) in the pulmonary parenchyma under the pleura. The visceral pleura surrounding the lesion was hyperemic and yellow-staining
(thick arrows).
Huang et al. European Journal of Medical Research 2013, 18:13 Page 2 of 6
http://www.eurjmedres.com/content/18/1/13
serologic assays did not corroborate the symptoms and
signs. Although lung endometriosis was greatly suspected
in this patient, she rejected medical treatment for fear of
adverse hormonal side effects. Subsequently, this patient
suffered a poorer quality of life during one year of catame-
nial hemoptysis.
A decision to proceed to biopsy was made based on
symptoms, signs, and the results of the respiration func-
tion test. From the biopsied sample the pathology report
confirmed the suspected diagnosis, and a radical resec-
tion was subsequently performed. During the explora-
tory thoracotomy, a phlyctenular apophysis, 2 cm × 2
cm, was detected on the surface of the lingular segment
of the left superior lobe with no further macro-
scopic signs of external endometriosis (Figure 1C). Albu-
terol 0.83% 5 mL was administered by nebulization
twice a day before the surgical procedure. No further
hemoptysis was observed at the end of her period after
she was admitted. Finally, after the procedure the patient
received 5 days of fluid therapy with antibiotic
levofloxacin 0.5 (erase 0.5 and add 500 mg) intravenous
once a day, as well as sputum therapy with mucosolvan®
90 mg intravenous once a day. The patient was
discharged to home on the ninth day in a good condi-
tion. The pleura at the site of the lesions’ surfaces was
impaired.
Pathology
Gross specimen
The specimen comprised the upper lobe of the left su-
perior lobe, 16.0 cm × 9.0 cm × 4.0 cm. It contained an
irregular dark-red lesion, 5 cm × 4 cm × 4 cm, with an
obscure boundary 4 cm from the bronchus. The stiffness
of the lesion was moderate to mild (Figure 1D).
Microscopy
Under low-power microscopy, the atypical tubular-gland
structures of the lesions were visible in the alveoli
and were arrayed as columnar and cubical epithe-
lia, surrounded by a large number of lymphocytes
(Figure 2A). In the alveolar space, a large number of red
blood cells and phagocytic cells were intermingled. The
alveolar walls were infiltrated by plasma cells and lym-
phocytes (Figure 2B). Immunohistochemical reactions
revealed the presence of CD68+ (Figure 2C) and CK7+
(Figure 2D). The postoperative course was uneventful,
Figure 2 Staining of pulmonary parenchyma. H&E: (A) Atypical tubular-gland structures of decidual lesions were detected in the alveolar
space (thin arrow). Structure of alveolar wall (thick arrow); 100×. (B) The alveolar spaces were filled with many red blood cells and phagocytic
cells with hemosiderin (thick arrow). The alveolar walls were infiltrated by plasma cells (triangular arrow) and lymphocytes (thin arrow); 200×.
Immunohistochemical staining: (C) Phagocytic cells in the alveolar space, CD68+ (heavy arrow). Plasma cells and lymphocytes in the alveolar
walls, CD68– (thin arrow), H&E 200×. (D) Gland epithelium in an alveolus, CK7+ (thick arrow). Infiltrating plasma cells and lymphocytes in the
alveolar wall, CK7– (thin arrow), H&E 200×. H&E: hematoxylin and eosin (correct).
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and the patient was discharged 11 days after surgery.
She has been asymptomatic for 2 years without any re-
currence of hemoptysis.
Conclusion
Endometriosis is characterized mainly by the presence of
ectopic endometrial glands outside the uterine cavity. It
was first reported by Carl von Rokitansky in 1860 [12],
who named the condition ‘adenomyoma’. The pathogen-
esis of endometriosis is ascribed to one (or more) of
three mechanisms: the retrograde regurgitation of endo-
metrium through the oviducts during menstruation,
Müllerian metaplasia of coelomic epithelium, or lymph-
atic and venous dissemination of endometrial tissue to
distant sites with implantation [11].
Extra-pelvic (that is, non-gynecologic) endometriosis
has received special attention primarily because of the
diversity of affected sites and its unusual symptomatol-
ogy. Extra-pelvic endometriosis may occur in any of four
anatomical regions: the lungs, bowel-omentum, urinary
tract, and all other sites inclusive [13]. Explanations for
the spread of endometrial tissues to distant sites rest on
hypotheses of venous or lymphatic circulation, or analo-
gies to the metastatic spread of neoplasms [13]. There-
fore, the hypothesis is that endometriosis does not result
solely from retrograde bleeding, but also from endomet-
rial cells that are shed in the pelvic cavity and which
have a tendency to implant and proliferate [14-16].
New insights into the etiology and pathogenesis of this
disease serve as a background for new treatments for
disease-associated pain and infertility. Possible causal
and supportive factors include genetic susceptibility, en-
vironmental factors, the immune system, intrinsic endo-
metrial abnormalities, and the secreted products of
endometriotic lesions [17]. Importantly, affected women
are at higher risk than the general female population of
developing ovarian cancer, and may also be at increased
risk of breast and other cancers, as well as autoimmune
and atopic disorders. However, there may soon be a new
repertoire of approaches for treatment and perhaps cure
of this enigmatic disorder in the near future.
Endometriosis of the lung is a clinically serious form of
the disease, which requires careful differential diagnosis,
as in the present case. Our patient complained of
hemoptysis, a clinical symptom of thoracic endometriosis,
as is hematothorax and pneumothorax. Menstruation-
related hemoptysis is not obviously present in all patients,
and accurate diagnosis of thoracic endometriosis is always
difficult to make. Fortunately, our patient presented with
catamenial hemoptysis. Due to our interest in this case,
we also reviewed 74 cases of catamenial hemoptysis that
have been reported since 1956 [18] in which ectopic endo-
metriosis was identified: 37 cases (59.6%) (please correct
to 0.5) were in the right lung, 19 (30.6%) in the left, and 6
(9.7%) were bilateral. In 61 of 70 patients (87.1%) who
underwent gynecological examinations, no evidence of
pelvic endometriosis was found [1,6-8,18-21]. Addition-
ally, 58 of 73 cases (80.6%) (please correct to 74 and add-
itionally correct the percentage)showed a history of
gynecological disorders. These observations support the
embolization theory as the underlying cause of ectopic
endometriosis in the respiratory tract.
While in our case there was no proven pelvic endo-
metriosis or gynecological disease, our patient has previ-
ously undergone induced abortions, and there were two
cases in the literature review in which induced abortion
may have caused endometriosis in the respiratory sys-
tem. The CT findings for pulmonary endometriosis may
include well-defined opacities, nodular lesions, thin-wall
cavities, or bullous formations, but most cases involving
hemoptysis have transient radiologic densities in the af-
fected part of the lung [22]. In our patient, the CT im-
ages taken during her menstrual period showed a
radiographic opacity at the distal end of the left superior
lobe. Of note, there was also active bleeding in the distal
bronchus of the superior segment of the left lingular
lobe detected by bronchoscopy on the fourth day of the
menstrual cycle, which further strengthened the clinical
diagnosis in the view of the CT finding. Ultimately,
histopathological confirmation of ectopic endometriosis
was obtained after exploratory thoracotomy.
In general, the initially important diagnostic criterion for
this disease is presentation of periodic hemoptysis that is
synchronous with menstruation. Most previously reported
cases were diagnosed based on the clinical history of the
patient; a histological confirmation of ectopic endometri-
osis is not always done. Fortunately, in the patient
reported here, ectopic endometrium was found in the pul-
monary parenchyma, and infiltration of hemosiderin-
laden macrophages was observed that were the result of
repeated bleeding episodes.
Patients with lung endometriosis usually undergo either
surgery or hormonal treatments. However, no large-scale
randomized trial has been conducted and the optimal
treatment regimen remains controversial. Recently, video-
assisted thoracic surgery for catamenial hemoptysis was
reported, which was found to be safer and less invasive
than lobectomy [9,14,23]. When the bleeding site is
confirmed by bronchoscopy and it is determined to be
distributed within one lobe, the surgical approach is
considered appropriate for the disease, especially when
the patient desires a pregnancy in the future or if they
are worried about possible complications related to hor-
monal treatments. In addition, the treatment of catame-
nial hemoptysis by endoscopic laser ablation has also
been reported, and this treatment modality should be
considered if the lesion can be clearly detected by bron-
choscopy [11,13].
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In the current case, a lobectomy provided a favorable
outcome for this benign lesion, and endometriosis was
confirmed via postoperative histopathology. Because of
the history of hemoptysis synchronous with the menstrual
cycle, an immunohistochemistry test was performed to en-
sure the preoperative diagnosis. Although we performed a
lobectomy rather than the more minimally invasive video-
assisted thoracic surgery (because the patient could not af-
ford it), endometriosis-associated events were not present
during the postoperative 2-year follow-up. Lobectomy was
appropriate for the treatment of lung endometriosis in the
present case, and its success lends support for the efficacy
and safety of lobectomy for this disorder.
Further studies and a more extensive literature search
are required to determine the best course of treatment
for patients presenting with this rare disease. Systems
biological approaches with patients and morphology-
based mathematical modeling could be valuable for
studying aspects of pathophysiology and for comparing
variants of therapeutic modalities in depth. For the ma-
jority of women with endometriosis, the disease imposes
a substantial toll in terms of well-being, personal rela-
tionships, time away from work, and the need for sur-
gery and expensive therapies [24]. Furthermore, the
increased risk of ovarian cancer and possible increased
risks of autoimmune diseases and breast and skin can-
cers further support a need for multidisciplinary care
and long-term follow-up of women with this disorder
[17].
For women in whom lung endometriosis is suspected,
a current history of catamenial hemoptysis, active bleed-
ing observed by bronchoscopy, and evidence from CT
scans justify the preliminary diagnosis. The endometri-
osis patient’s history, environmental exposures, family
history, and physical examination are considered just as
important for assessment and care. Surgical removal re-
mains the accepted treatment for the disease, and is sup-
ported by the outcome of our case. Appropriately
designed clinical trials are essential for determining
which therapies are safe and effective.
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